Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

TTD

Trade Desk Inc

Feb 13 • 04:00PM ET

25.81

-0.33 -1.26 %

Communication Services • Advertising Agencies • USA • NASD

Peers: GOOGL ROKU MGNI PUBM PERI APPS SNAP SPOT TME

| Held by: VTI VOO XLC VO VUG IVV VOT SPY RSP IWP

Index	S&P 500	P/E	29.45	EPS (ttm)	0.88	Insider Own	9.56%	Shs Outstand	441.45M	Perf Week	-4.55%
Market Cap	12.48B	Forward P/E	23.59	EPS next Y	1.09	Insider Trans	-0.00%	Shs Float	437.36M	Perf Month	-30.49%
Enterprise Value	11.41B	PEG	-	EPS next Q	0.34	Inst Own	75.06%	Short Float	10.09%	Perf Quarter	-41.06%
Income	438.58M	P/S	4.47	EPS this Y	-48.52%	Inst Trans	3.49%	Short Ratio	3.33	Perf Half Y	-49.15%
Sales	2.79B	P/B	4.81	EPS next Y	28.01%	ROA	7.66%	Short Interest	44.13M	Perf YTD	-32.01%
Book/sh	5.37	P/C	8.64	EPS next 5Y	-5.45%	ROE	16.78%	52W High	91.45 -71.78%	Perf Year	-68.49%
Cash/sh	2.99	P/FCF	18.10	EPS past 3/5Y	41.52% 28.15%	ROIC	15.10%	52W Low	25.93 -0.48%	Perf 3Y	-46.93%
Dividend Est.	-	EV/EBITDA	17.95	Sales past 3/5Y	26.90% 29.90%	Gross Margin	78.81%	Volatility	4.51% 4.43%	Perf 5Y	-70.13%
Dividend TTM	-	EV/Sales	4.09	EPS Y/Y TTM	41.82%	Oper. Margin	18.91%	ATR (14)	1.40	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.71	Sales Y/Y TTM	20.82%	Profit Margin	15.72%	RSI (14)	25.06	Recom	2.05
Dividend Gr. 3/5Y	- -	Current Ratio	1.71	EPS Q/Q	25.08%	SMA20	-15.32%	Beta	1.12	Target Price	53.91
Payout	0.00%	Debt/Eq	0.14	Sales Q/Q	17.74%	SMA50	-26.16%	Rel Volume	1.00	Prev Close	26.14
Employees	3522	LT Debt/Eq	0.12	Earnings	Feb 25 AMC	SMA200	-52.34%	Avg Volume	13.27M	Price	25.81
IPO	Sep 21, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.43% 2.78%	Trades		Volume	13,239,323	Change	-1.26%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-23-26	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
Jan-14-26	Initiated	BNP Paribas Exane	Neutral	$40
Jan-12-26	Upgrade	MoffettNathanson	Sell → Neutral	$39
Dec-08-25	Reiterated	Wedbush	Neutral	$50 → $40
Nov-07-25	Upgrade	The Benchmark Company	Hold → Buy	$65
Oct-06-25	Reiterated	Wells Fargo	Equal Weight	$68 → $53
Sep-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$50
Aug-11-25	Downgrade	Jefferies	Buy → Hold	$50
Aug-11-25	Downgrade	HSBC Securities	Buy → Hold	$56
Aug-08-25	Downgrade	Wedbush	Outperform → Neutral	$68
Aug-08-25	Downgrade	MoffettNathanson	Neutral → Sell	$45
Aug-08-25	Downgrade	Citigroup	Buy → Neutral	$65
Aug-08-25	Downgrade	BTIG Research	Buy → Neutral
Aug-08-25	Downgrade	BofA Securities	Buy → Underperform	$55
Aug-08-25	Downgrade	BofA Securities	Buy → Neutral	$55
Jul-01-25	Reiterated	Citigroup	Buy	$82 → $90
Jun-27-25	Upgrade	Evercore ISI	In-line → Outperform	$90
Jun-26-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$68
May-09-25	Reiterated	Wedbush	Outperform	$80 → $86
May-09-25	Reiterated	Truist	Buy	$95 → $100

Show Previous Ratings

Today 08:41AM	Analysts Maintain Buy Ratings on The Trade Desk (TTD) Amid Lower EV/EBITDA Multiples (Insider Monkey)
Feb-13-26 10:59AM	AppLovin Rides on Margin Power: Here's What You Should Know (Zacks)
Feb-11-26 05:45PM	Here's Why The Trade Desk (TTD) Fell More Than Broader Market (Zacks)
Feb-09-26 08:54AM	TTD Slides 27% in the Past Month: Hold the Stock or Trim Losses? (Zacks)
Feb-07-26 03:33AM	Trade Desk (TTD) Sees Major Divestment from ETF (Insider Monkey)
12:32AM	Loading…
Feb-06-26 12:32AM	Leadership Transition Tempers Analyst Sentiment on Trade Desk (TTD) (Insider Monkey)
Feb-05-26 03:45PM	The Trade Desk, SentinelOne, GitLab, Guidewire Software, and Rapid7 Shares Are Falling, What You Need To Know (StockStory)
08:28AM	Analysts Love These 3 Stocks Trading Near 52-Week Lows-Here's Why (MarketBeat)
Feb-04-26 05:10PM	Alphabet Inc. (GOOG) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
01:39PM	Jim Cramer on Trade Desk: "I Think It's Just Not Worth the Risk" (Insider Monkey)
09:00AM	The Trade Desk (TTD) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:44AM	Should You Buy The Trade Desk After Its 67% Slump in 2025? (Motley Fool)
06:09AM	Trade Desk Extends Losses After KeyBanc Slashes Target (GuruFocus.com)
Feb-03-26 03:48PM	Why The Trade Desk Stock Plunged to a New 5-Year Low Today (Motley Fool) -8.64%
03:42PM	Trade Desk Stock Drops After Keybanc Cuts Target (Benzinga)
11:34AM	Loading…
11:34AM	Jim Cramer on Trade Desk: "Out of Left Field CFO Departure Equals Sell" (Insider Monkey)
11:20AM	Prediction: This Tech Stock Could Double Your Money by End of 2026 (Motley Fool)
10:00AM	25 Stocks to Buy for a Profitable February (Schaeffer's Research)
Feb-02-26 10:35PM	The Top 5 Stocks to Double Up on Right Now (Motley Fool)
09:50PM	The Trade Desk, Inc. (TTD): A Bull Case Theory (Insider Monkey)
06:52PM	Should You Buy The Trade Desk After Its 68% Slump in 2025? (Motley Fool)
05:45PM	The Trade Desk (TTD) Stock Declines While Market Improves: Some Information for Investors (Zacks)
03:08PM	Time to Cash Out? 4 Stocks to Sell Before Earnings (Motley Fool)
01:47AM	The Best Stocks to Invest $10,000 in to Start 2026 (Motley Fool)
Feb-01-26 02:31PM	UnitedHealth, Trade Desk, And Unity Are Among Top 10 Large Cap Losers Last Week (Jan. 26-Jan. 30): Are the Others in Your Portfolio? (Benzinga)
Jan-31-26 07:40AM	Got $5,000? 3 Stocks That Are No-Brainer Buys Now. (Motley Fool)
Jan-30-26 11:20AM	The 5 Best Stocks to Buy for 2026 (Motley Fool)
Jan-29-26 07:35PM	2 Struggling Stocks That Aren't Worth Buying on the Dip (Motley Fool)
10:07AM	Jim Cramer Issues Urgent Profit-Taking Warning to Start 2026 (24/7 Wall St.)
Jan-28-26 06:57AM	Optimism for Trade Desk (TTD) Following Solid Results Preview (Insider Monkey)
12:43PM	Loading…
Jan-27-26 12:43PM	Why The Trade Desk Fell Yet Again Today (Motley Fool)
11:44AM	The Trade Desk Stock Hits 52-Week Low In Wake Of Sudden CFO Departure (Benzinga)
11:41AM	Why The Trade Desk (TTD) Shares Are Sliding Today (StockStory)
11:16AM	Trade Desk stock hits new low after CFO departure (GuruFocus.com)
Jan-26-26 05:45PM	The Trade Desk (TTD) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks) -7.50%
03:42PM	Why The Trade Desk Stock Is Plummeting Today (Motley Fool)
02:05PM	Why Trade Desk's stock is the S&P 500's sharpest decliner on Monday (MarketWatch)
01:26PM	Natural Gas Rallies 30%, Silver Jumps 13% To $116: What's Moving Markets Monday? (Benzinga)
01:23PM	The Trade Desk Announces Its Second CFO Transition in Less Than 6 Months. Is This a Red Flag? (Motley Fool)
12:11PM	Why The Trade Desk (TTD) Shares Are Falling Today (StockStory)
11:11AM	The Trade Desk Stock Moves Lower Amid Management Shake-Up (Benzinga)
09:25AM	The Trade Desk Announces Tahnil Davis as Interim Chief Financial Officer (Business Wire)
04:00AM	Bear of the Day: HubSpot (HUBS) (Zacks)
Jan-24-26 06:26PM	This Growth Stock Has Been Absolutely Crushed. But Is It Finally Time to Buy? (Motley Fool)
Jan-23-26 03:43PM	Top Stocks to Double Up on Right Now (Motley Fool)
09:57AM	Stocks Pressured by Weakness in Chip Makers (Barchart)
09:41AM	Darden upgraded, Trade Desk downgraded: Wall Street's top analyst calls (The Fly)
08:05AM	Where Will The Trade Desk Stock Be in 5 Years? (Motley Fool)
Jan-22-26 03:49PM	Should You Buy The Trade Desk Stock Before the Q4 Report? (Motley Fool)
12:56PM	AppLovin's Price Volatility is a Feature, Not a Business Fall (Zacks)
Jan-21-26 09:00AM	The Trade Desk (TTD) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:44AM	Trade Desk price target lowered to $40 from $49 at BofA (TipRanks)
07:52AM	Strong Kokai Adoption Fuels TTD's Revenue Pipeline & Growth Prospects (Zacks)
06:17AM	UBS Cuts The Trade Desk Target to $50 (GuruFocus.com)
Jan-20-26 09:54PM	Software Stocks: From Market Leaders to AI Victims (Zacks)
04:15PM	The Trade Desk (TTD) Stock Hits New 52-Week Low As Tariff Fears Rattle Growth Tech (Benzinga)
09:32AM	TTD vs. MGNI: Which Ad-Tech Stock Is the Smarter Pick Now? (Zacks)
Jan-19-26 09:20PM	3 Stocks to Buy in 2026 Before They Skyrocket (Motley Fool)
12:57PM	APP Stock Declines 22.5% in a Month: Should You Buy the Dip? (Zacks)
12:50PM	3 No-Brainer Growth Stocks to Buy With $100 as 2026 Begins (Motley Fool)
Jan-17-26 12:35PM	3 Top Bargain Stocks Ready for a Bull Run (Motley Fool)
05:30AM	Supersize CEO Pay Packages Aren't Paying Off for Shareholders (The Wall Street Journal)
Jan-16-26 12:09PM	AppLovin's Scalable Ad Engine Emerges as the Real Growth Catalyst (Zacks)
08:50AM	5 Bargain Stocks That Could Deliver Jaw-Dropping Returns in 2026 (Motley Fool)
Jan-15-26 11:20PM	The Best Stocks to Invest $10,000 in Right Now (Motley Fool)
05:45PM	The Trade Desk (TTD) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
08:15AM	Stifel Reaffirms The Trade Desk, Inc. (TTD) as Sector Favorite Amid Market Volatility (Insider Monkey)
Jan-14-26 12:52PM	Is The Trade Desk (TTD) One of the Best Fundamental Stocks to Buy According to Analysts? (Insider Monkey)
Jan-13-26 04:26AM	3 No-Brainer Stocks to Buy With $1,000 Right Now for the New Year (Motley Fool)
Jan-12-26 04:24PM	2 Tech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
12:10PM	Trade Desk's stock has never been this cheap, and its brutal selloff might finally be over (MarketWatch)
Jan-11-26 11:35PM	1 Cash-Producing Stock Worth Your Attention and 2 We Turn Down (StockStory)
01:59PM	Is The Trade Desk (TTD) One of the Oversold Fundamentally Strong Stocks to Buy Right Now? (Insider Monkey)
11:13AM	3 Absurdly Cheap Stocks That Could Double in 2026 (Motley Fool)
Jan-08-26 11:46AM	Why the Trade Desk Stock Collapsed 68% In 2025 (Motley Fool)
08:11AM	The Trade Desk Slumps 68% in the Past Year: How to Approach the Stock? (Zacks)
08:02AM	Can Trade Desk's OpenAds Make Media Supply Chains Healthier? (Zacks)
07:44AM	Jim Cramer Says "The Trade Desk Still Needs to Figure Out Where It Fits in the World" (Insider Monkey)
Jan-07-26 11:34PM	1 Stock Under $50 Worth Your Attention and 2 That Underwhelm (StockStory)
05:45PM	The Trade Desk (TTD) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
03:35PM	Is Now the Time to Buy 3 of the S&P 500's Worst-Performing Stocks of 2025? (Motley Fool)
09:00AM	Investors Heavily Search The Trade Desk (TTD): Here is What You Need to Know (Zacks)
07:46AM	Can Trade Desk's CTV Momentum Hold Off Rising Competition? (Zacks)
Jan-06-26 11:04PM	3 Reasons Investors Love The Trade Desk (TTD) (StockStory)
09:00AM	The Trade Desk Announces First Wave of OpenAds Publishing Partners Supporting a Healthier Digital Media Supply Chain (Business Wire)
Jan-05-26 04:26AM	10 Magnificent Stocks That Can Make You Richer in 2026 (Motley Fool) +6.45%
Jan-03-26 08:31AM	3 Consumer Stocks Set for a Comeback in 2026 (Motley Fool)
07:50AM	3 Phenomenal Stocks That Could Double in 2026 (Motley Fool)
07:09AM	The Trade Desk (TTD) Has Fallen More Than 60% - but Analysts Are Turning Bullish Again (Insider Monkey)
Jan-02-26 05:42PM	The Trade Desk vs. SanDisk: Buying the Wreckage or the Winner? (MarketBeat) +6.45%
07:05AM	Kforce and Trex have been highlighted as Zacks Bull and Bear of the Day (Zacks)
05:26AM	7 Magnificent Stocks That Can Double Your Money in 2026 (Motley Fool)
Jan-01-26 11:38PM	1 Profitable Stock Worth Your Attention and 2 We Turn Down (StockStory)
Dec-31-25 01:47PM	3 Beaten-Down Stocks That Could Rebound in 2026 (Zacks)
10:52AM	AppLovin's High Revenue-to-Profit Conversion is the Story (Zacks)
10:36AM	Micron, Trade Desk, Western Digital: 2025's Big Stock Movers (The Wall Street Journal)
09:22AM	How Western Digital Became the S&P 500's Best Stock in 2025-and Why Trade Desk Was the Worst (Barrons.com)
07:55AM	Western Digital Ends 2025 as the S&P 500's Best Stock. This Ad-Tech Stock Had a Bleak Year. (Barrons.com)
03:26AM	Stock Market Today: Silver Prices Slide; S&P Futures Edge Down at Year End (The Wall Street Journal)
Dec-30-25 03:07AM	Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now (Motley Fool)

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Cunningham Andrea Lee	Director	Sep 10 '25	Sale	48.20	1,403	67,625	5,035	Sep 12 06:07 PM
ANDREA L CUNNINGHAM	Director	Sep 10 '25	Proposed Sale	48.20	1,403	67,625		Sep 10 04:58 PM
GRANT JAY R	Chief Legal Officer	Aug 07 '25	Option Exercise	63.01	30,963	1,950,961	254,103	Aug 11 06:05 PM
GRANT JAY R	Chief Legal Officer	Aug 07 '25	Sale	91.18	51,290	4,676,679	218,246	Aug 11 06:05 PM
JAY GRANT	Officer	Aug 07 '25	Proposed Sale	91.18	51,290	4,676,725		Aug 07 04:02 PM
Schenkein Laura	Chief Financial Officer	May 16 '25	Sale	76.66	4,809	368,662	745,902	May 19 07:19 PM
LAURA SCHENKEIN	Officer	May 16 '25	Proposed Sale	76.67	4,809	368,682		May 16 04:08 PM
WELLS DAVID B	Director	May 13 '25	Option Exercise	58.28	28,638	1,669,057	95,623	May 15 05:05 PM
WELLS DAVID B	Director	May 13 '25	Sale	79.88	28,638	2,287,603	66,985	May 15 05:05 PM
Green Jeffrey Terry	President and CEO	May 12 '25	Sale	80.03	26,684	2,135,521	17,018	May 14 04:35 PM
Green Jeffrey Terry	President and CEO	May 13 '25	Sale	80.06	3,193	255,640	17,018	May 14 04:35 PM
WELLS DAVID B	Director	May 13 '25	Proposed Sale	79.88	28,638	2,287,700		May 13 07:25 PM
Green Jeffrey Terry	Officer	May 13 '25	Proposed Sale	80.03	396	31,691		May 13 04:46 PM
Schenkein Laura	Chief Financial Officer	May 09 '25	Sale	70.00	6,374	446,180	756,481	May 13 04:39 PM
Green Jeffrey Terry	Officer	May 12 '25	Proposed Sale	80.00	2,739	219,109		May 12 05:09 PM
LAURA SCHENKEIN	Officer	May 09 '25	Proposed Sale	70.00	6,374	446,180		May 09 04:04 PM

Open in Screener

NUVB

Nuvation Bio Inc

Feb 13 • 04:00PM ET

5.77

-0.02 -0.35 %

Healthcare • Biotechnology • USA • NYSE

Peers: GILD AMGN REGN VRTX BIIB MRNA BMY PFE LLY SNY

| Held by: VTI IWM VXF IWN VTWO IBB SCHA VHT XPH IWC

Index	RUT	P/E	-	EPS (ttm)	-0.64	Insider Own	30.38%	Shs Outstand	341.76M	Perf Week	1.23%
Market Cap	1.98B	Forward P/E	-	EPS next Y	-0.41	Insider Trans	-0.84%	Shs Float	239.39M	Perf Month	-8.56%
Enterprise Value	1.64B	PEG	-	EPS next Q	-0.09	Inst Own	52.00%	Short Float	20.44%	Perf Quarter	17.04%
Income	-217.48M	P/S	74.17	EPS this Y	72.15%	Inst Trans	-1.18%	Short Ratio	6.69	Perf Half Y	109.06%
Sales	26.75M	P/B	6.07	EPS next Y	30.86%	ROA	-37.08%	Short Interest	48.92M	Perf YTD	-35.60%
Book/sh	0.95	P/C	3.61	EPS next 5Y	64.47%	ROE	-52.49%	52W High	9.75 -40.82%	Perf Year	151.97%
Cash/sh	1.60	P/FCF	-	EPS past 3/5Y	-68.86% -49.14%	ROIC	-41.78%	52W Low	1.54 274.68%	Perf 3Y	167.13%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	48.95%	Volatility	6.62% 6.80%	Perf 5Y	-35.89%
Dividend TTM	-	EV/Sales	61.42	EPS Y/Y TTM	70.51%	Oper. Margin	-870.98%	ATR (14)	0.42	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.39	Sales Y/Y TTM	1137.19%	Profit Margin	-813.07%	RSI (14)	40.77	Recom	1.18
Dividend Gr. 3/5Y	- -	Current Ratio	8.48	EPS Q/Q	-8.23%	SMA20	1.37%	Beta	1.50	Target Price	11.90
Payout	-	Debt/Eq	0.64	Sales Q/Q	1704.68%	SMA50	-21.07%	Rel Volume	0.34	Prev Close	5.79
Employees	220	LT Debt/Eq	0.60	Earnings	Nov 03 AMC	SMA200	35.48%	Avg Volume	7.32M	Price	5.77
IPO	Aug 26, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.16% 98.51%	Trades		Volume	2,505,364	Change	-0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-24-25	Initiated	Truist	Buy
Nov-19-25	Initiated	B. Riley Securities	Buy	$12
Sep-30-25	Initiated	Jefferies	Buy	$10
Apr-23-25	Initiated	Citizens JMP	Mkt Outperform	$6
Mar-27-24	Upgrade	Jefferies	Hold → Buy	$1.40 → $10
Mar-26-24	Upgrade	BTIG Research	Neutral → Buy	$5
Jan-06-23	Downgrade	Jefferies	Buy → Hold	$5 → $2
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$8 → $2.50
May-04-22	Initiated	H.C. Wainwright	Buy	$14
Oct-15-21	Resumed	BTIG Research	Buy	$16
Apr-06-21	Initiated	RBC Capital Mkts	Outperform	$15
Mar-08-21	Initiated	Wedbush	Outperform	$20
Mar-08-21	Initiated	Jefferies	Buy	$20
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	BTIG Research	Buy	$16
Mar-08-21	Initiated	BMO Capital Markets	Outperform	$16

Show Previous Ratings

Feb-09-26 08:00AM	Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma (Business Wire)
Jan-30-26 09:47AM	Turist Financial Remains a Buy on Nuvation Bio (NUVB) (Insider Monkey)
12:24AM	Truist Highlights Nuvation Bio's (NUVB) Ibtrozi's Robust Market Uptake and Lead Over Competitors (Insider Monkey)
Jan-28-26 08:28AM	Nuvation Bio price target raised to $13 from $11 at Truist (TipRanks) -5.53%
Jan-20-26 04:59AM	Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations (Insider Monkey)
08:01AM	Loading…
Jan-19-26 08:01AM	Here's What the Wall Street Thinks About Nuvation Bio Inc. (NUVB) (Insider Monkey)
Jan-15-26 11:35AM	Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib (Insider Monkey)
Jan-13-26 09:35AM	Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround (Zacks)
Jan-12-26 08:00AM	Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference (Business Wire) -19.65%
07:30AM	Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan (Business Wire)
Jan-06-26 04:05PM	Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-05-26 09:55AM	Wall Street Analysts Think Nuvation Bio (NUVB) Could Surge 32.05%: Read This Before Placing a Bet (Zacks)
Dec-19-25 09:55AM	Wall Street Analysts Believe Nuvation Bio (NUVB) Could Rally 25.14%: Here's is How to Trade (Zacks) +5.01%
Dec-15-25 12:00PM	Nuvation Bio (NUVB) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-06-25 10:40PM	Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List (PR Newswire)
12:55PM	Loading…
Dec-04-25 12:55PM	Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result (Insider Monkey)
Dec-03-25 08:00AM	Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology (Business Wire) +12.05%
Nov-26-25 04:05PM	Nuvation Bio to Participate in Upcoming Investor Conferences (Business Wire)
Nov-20-25 06:27AM	Nuvation Bio (NUVB) Jumps to 3-Year High on Bullish Coverage (Insider Monkey)
Nov-18-25 06:17AM	Nuvation Bio Inc. (NUVB) is a Buy at H.C. Wainwright on Cancer Drug Development Progress (Insider Monkey)
Nov-07-25 09:34PM	Is Nuvation Bio (NUVB) One of the Best American Penny Stocks to Buy? (Insider Monkey) -5.78%
Nov-04-25 12:01AM	Nuvation Bio Inc (NUVB) Q3 2025 Earnings Call Highlights: Strong IBTROZI Launch and Robust ... (GuruFocus.com) -6.58%
Nov-03-25 05:55PM	Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update (Business Wire)
Oct-31-25 09:22AM	Nuvation Bio Inc (NUVB) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-30-25 04:05PM	Nuvation Bio to Participate in Upcoming Investor Conferences (Business Wire)
Oct-29-25 05:25PM	MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates (Zacks)
Oct-23-25 07:30AM	Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma (Business Wire) +5.78%
Oct-20-25 04:05PM	Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025 (Business Wire) +8.50% +13.78%
Oct-08-25 01:02PM	Nuvation Bio Inc. (NUVB): A Bull Case Theory (Insider Monkey)
08:55AM	Loading…
08:55AM	NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street (PR Newswire)
Sep-30-25 11:33AM	Why Nuvation Bio Stock Is Skyrocketing Today (Motley Fool) +14.91%
07:30AM	Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer (Business Wire)
Sep-19-25 07:30AM	Nuvation Bio Receives Approval from Japan's Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer (Business Wire)
Sep-07-25 06:00AM	Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer (Business Wire)
Aug-27-25 04:05PM	Nuvation Bio to Participate in Upcoming Investor Conferences (Business Wire)
09:55AM	Nuvation Bio Inc. (NUVB) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Aug-25-25 11:56PM	H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB) (Insider Monkey)
Aug-07-25 08:45AM	Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
07:30AM	Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update (Business Wire)
Aug-06-25 05:15PM	Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-05-25 08:00AM	Nuvation Bio To Present New Data on IBTROZI (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses (Business Wire)
Aug-01-25 06:46AM	Nuvation Bio (NUVB)'s Taletrectinib Selected as Preferred Agent for Cancer Treatment (Insider Monkey) -5.51%
Jul-24-25 04:05PM	Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 (Business Wire)
Jul-10-25 09:20AM	Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up (PR Newswire)
Jul-09-25 12:00PM	All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy (Zacks) +15.61%
Jun-29-25 03:00AM	Two Beaten-Down Biotech Stocks See Big Insider Buys (Barrons.com)
Jun-24-25 05:33PM	RBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy Rating (Insider Monkey) -8.29%
07:00AM	Nuvation Bio Announces National Comprehensive Cancer Network Adds Taletrectinib (IBTROZI) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers (Business Wire)
Jun-20-25 02:25PM	Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now? (Barchart) +10.06%
Jun-11-25 01:20PM	U.S. Food and Drug Administration Approves Nuvation Bios IBTROZI (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer (Business Wire) -13.04%
12:52AM	FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche (BioPharma Dive)
May-21-25 04:05PM	Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting (Business Wire) -6.45% +10.84%
May-13-25 04:05PM	Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025 (Business Wire)
May-12-25 04:05PM	Nuvation Bio to Participate in Upcoming Investor Conferences (Business Wire)
May-09-25 01:00PM	Nuvation Bio Inc (NUVB) Q1 2025 Earnings Call Highlights: Promising Developments and Strategic Moves (GuruFocus.com)
04:31AM	Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams' Stock Picks with Huge Upside Potential (Insider Monkey)
May-07-25 06:35PM	Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update (Business Wire)
09:07AM	Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (Seeking Alpha)
May-01-25 04:05PM	Nuvation Bio to Present at The Citizens Life Sciences Conference (Business Wire) +8.37%
Apr-22-25 04:05PM	Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025 (Business Wire)
Apr-16-25 10:03AM	Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds? (Insider Monkey) -6.93%
Apr-13-25 05:40PM	Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? (Insider Monkey)
Apr-09-25 09:43AM	Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple (Insider Monkey) +7.83%
Apr-02-25 08:00AM	Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference (Business Wire)
Mar-25-25 04:45PM	Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 (Business Wire)
08:00AM	Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 (Business Wire)
Mar-17-25 03:47PM	Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts? (Insider Monkey)
Mar-09-25 04:11AM	Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts (Insider Monkey)
Mar-06-25 04:30PM	Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (Business Wire) +6.88%
Mar-04-25 05:11AM	Nuvation Bio secures $250m for taletrectinib commercialisation (Pharmaceutical Technology)
Mar-03-25 08:35AM	Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners (Business Wire) -7.61%
Feb-24-25 08:00AM	Nuvation Bio to Present at the TD Cowen 45th Annual Health Care Conference (Business Wire) -5.88%
Feb-03-25 08:00AM	Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer (Business Wire)
Jan-06-25 04:05PM	Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire) +14.44%
08:00AM	Nuvation Bio Receives Approval from Chinas National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer (Business Wire)
Dec-30-24 03:00PM	Why Is Nuvation Bio (NUVB) the Best Biotech Penny Stock to Invest in Now? (Insider Monkey) -5.07%
Dec-23-24 08:00AM	U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bios New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer (Business Wire)
Dec-20-24 07:10AM	Innovent Receives Approval of DOVBLERON (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration (PR Newswire)
Nov-26-24 08:00AM	Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-12-24 04:05PM	Nuvation Bio to Present at the Jefferies London Healthcare Conference (Business Wire)
Nov-06-24 04:05PM	Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update (Business Wire) +9.48%
01:11AM	Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline (Insider Monkey)
Oct-16-24 09:06AM	Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? (Insider Monkey) +10.30%
Oct-14-24 11:51AM	Is Nuvation Bio Inc. (NUVB) Hedge Funds Favorite Penny Stock? (Insider Monkey)
Oct-09-24 08:02AM	Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 (Insider Monkey)
Oct-07-24 04:05PM	Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer (Business Wire) -9.96%
Oct-02-24 02:02AM	Navigating Legal Uncertainty: Nuvation Bio Inc.s Chinese Operations and the Shifting Landscape of Chinas Civil Law System (TipRanks)
Sep-14-24 03:05AM	Positive Pooled Data from Nuvation Bio's TRUST-I and TRUST-II Studies Highlight Taletrectinib's Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024 (Business Wire)
Sep-09-24 08:00AM	Nuvation Bio to Present at the Cantor Global Healthcare Conference (Business Wire) +6.45%
Aug-06-24 06:32AM	Nuvation Bio pauses oncology drug after Phase I efficacy and safety analysis (Clinical Trials Arena) -6.29%
Aug-05-24 02:27PM	Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data (Benzinga) -5.36%
08:00AM	Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Jul-23-24 04:05PM	Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib (Business Wire) +10.06%
Jun-02-24 01:13AM	Innovent Announces TaletrectinibROS1 InhibitorUpdated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting (PR Newswire)
Jun-01-24 08:10AM	Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting (Business Wire)
May-29-24 04:05PM	Nuvation Bio to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-14-24 10:54PM	NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024 (InvestorPlace)
05:08PM	Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours (MT Newswires)

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Liu Dongfang	CHIEF MEDICAL OFFICER	Dec 01 '25	Option Exercise	2.93	150,000	439,500	168,000	Dec 03 05:02 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Dec 01 '25	Sale	7.82	150,000	1,173,255	18,000	Dec 03 05:02 PM
DONGFANG LIU	Officer	Dec 01 '25	Proposed Sale	7.82	150,000	1,173,255		Dec 01 04:51 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 25 '25	Option Exercise	3.61	10,000	36,100	28,000	Nov 26 05:55 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 26 '25	Option Exercise	3.61	10,000	36,100	28,000	Nov 26 05:55 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 26 '25	Sale	8.00	10,000	80,000	18,000	Nov 26 05:55 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 25 '25	Sale	7.50	10,000	75,000	18,000	Nov 26 05:55 PM
DONGFANG LIU	Officer	Nov 26 '25	Proposed Sale	8.00	10,000	80,000		Nov 26 04:33 PM
DONGFANG LIU	Officer	Nov 25 '25	Proposed Sale	7.50	10,000	75,000		Nov 25 04:23 PM
Hattersley Gary	CHIEF SCIENTIFIC OFFICER	Nov 20 '25	Option Exercise	1.90	369,051	702,149	300,000	Nov 24 04:09 PM
Hattersley Gary	CHIEF SCIENTIFIC OFFICER	Nov 20 '25	Sale	7.23	369,051	2,667,132	0	Nov 24 04:09 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 20 '25	Option Exercise	1.87	20,000	37,400	38,000	Nov 24 04:08 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 20 '25	Sale	7.00	20,000	140,074	18,000	Nov 24 04:08 PM
Hanley David C.	CHIEF TECHNICAL OPERATIONS	Nov 19 '25	Option Exercise	1.87	200,000	374,000	224,000	Nov 21 04:05 PM
Hanley David C.	CHIEF TECHNICAL OPERATIONS	Nov 19 '25	Sale	7.14	200,000	1,427,680	24,000	Nov 21 04:05 PM
GARY HATTERSLEY	Officer	Nov 20 '25	Proposed Sale	7.23	369,051	2,667,132		Nov 20 04:12 PM
DONGFANG LIU	Officer	Nov 20 '25	Proposed Sale	7.00	20,000	140,074		Nov 20 04:07 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 17 '25	Option Exercise	1.87	15,000	28,050	30,000	Nov 19 04:47 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 19 '25	Option Exercise	1.87	15,000	28,050	30,000	Nov 19 04:47 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 19 '25	Sale	5.10	15,000	76,552	18,000	Nov 19 04:47 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	Nov 17 '25	Sale	4.76	15,000	71,475	15,000	Nov 19 04:47 PM
DONGFANG LIU	Officer	Nov 19 '25	Proposed Sale	5.10	15,000	76,552		Nov 19 04:18 PM
DAVID HANLEY	Officer	Nov 19 '25	Proposed Sale	7.14	200,000	1,427,680		Nov 19 04:09 PM
DONGFANG LIU	Officer	Nov 17 '25	Proposed Sale	4.76	15,000	71,475		Nov 17 04:12 PM
Hattersley Gary	CHIEF SCIENTIFIC OFFICER	Oct 27 '25	Option Exercise	1.74	100,000	174,000	100,000	Oct 29 04:24 PM
Hattersley Gary	CHIEF SCIENTIFIC OFFICER	Oct 27 '25	Sale	5.02	100,000	502,460	0	Oct 29 04:24 PM
GARY HATTERSLEY	Officer	Oct 27 '25	Proposed Sale	4.85	100,000	485,000		Oct 27 04:26 PM
Markel Stacy	CHIEF PEOPLE OFFICER	Jun 18 '25	Buy	1.71	10,000	17,100	29,591	Jun 18 04:05 PM
Sauvage Philippe	Chief Financial Officer	Jun 17 '25	Buy	1.79	4,000	7,160	9,902	Jun 18 04:05 PM
Sauvage Philippe	Chief Financial Officer	Jun 16 '25	Buy	1.83	3,300	6,056	5,902	Jun 18 04:05 PM
Sjogren Colleen	Chief Commercial Officer	Jun 16 '25	Buy	1.81	50,000	90,350	81,000	Jun 18 04:05 PM
Wentworth Kerry	CHIEF REGULATORY OFFICER	Jun 16 '25	Buy	1.79	50,000	89,740	50,000	Jun 18 04:05 PM
Hung David	PRESIDENT AND CEO	Jun 16 '25	Buy	1.79	500,000	893,500	59,281,054	Jun 18 04:05 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	May 02 '25	Option Exercise	1.94	20,000	38,800	32,000	May 06 04:05 PM
Liu Dongfang	CHIEF MEDICAL OFFICER	May 02 '25	Sale	2.50	20,000	50,024	12,000	May 06 04:05 PM
DONGFANG LIU	Officer	May 02 '25	Proposed Sale	2.27	20,000	45,400		May 02 04:23 PM
Hung David	PRESIDENT AND CEO	Apr 07 '25	Buy	1.62	300,000	487,500	58,781,054	Apr 08 09:30 PM
Hung David	PRESIDENT AND CEO	Apr 04 '25	Buy	1.66	200,000	332,720	58,481,054	Apr 08 09:30 PM
Mashal Robert	Director	Apr 01 '25	Buy	1.67	100,000	166,985	200,000	Apr 03 04:05 PM

TTD

Trade Desk Inc

NUVB

Nuvation Bio Inc

Upgrade your FINVIZ experience